Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 114

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 114
---
 uncertainties that could cause actual results to differ materially from those reflected in these forward-looking statements. Further, as a result of these factors, risks and uncertainties, the forward-looking events may not occur. Relevant factors, risks and uncertainties include, but are not limited to, those discussed in the section entitled “Business,” “Risk Factors” and elsewhere in this prospectus. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s beliefs and opinions as of the date of this prospectus. We are not obligated to publicly update or revise any forward -looking statements, whether as a result of new information, future events or otherwise. See “Cautionary Note Regarding Forward-Looking Statements.”

Overview

NewGenIvf is an assisted
reproductive services (“ARS”) provider in Asia Pacific. Since the establishment of its first clinic in Thailand in 2014,
it has established itself as a long-standing ARS provider in the region. NewGenIvf’s mission is to assist couples and individuals
across Asia Pacific, regardless of fertility challenges that they may face, to fulfil their dreams of building families and to increase
their access to fertility treatments. Its strategic presence in Thailand, Cambodia, and Kyrgyzstan positions the company to take advantage
of opportunities across Asia Pacific.

NewGenIvf is still in the
early stage of materializing its long-term objective of building a comprehensive, sophisticated and high-end ARS platform for its clients
and providing personalized solutions based on NewGenIvf’s brands and client-generated services. NewGenIvf plans to offer full fertility
services for fertility tourists across Asia Pacific, continue to invest in laboratories and facilities updates, increase its brand awareness
and market share, as well as expand service reach through acquisitions and partnerships, which NewGenIvf believes will help expand its
client base and enhance expertise attraction, and in turn strengthen NewGenIvf’s monetization capabilities.

Key Factors Affecting NewGenIvf’s Results of Operations

NewGenIvf’s results
of operation are principally affected by the following factors:

Regulatory environment

The ARS market in Asia-Pacific
region is highly regulated. The implementation and enforcement of laws, regulations and government policies in Thailand, Cambodia, Kyrgyzstan
and other applicable jurisdictions significantly impact the design, pricing and sale of fertility services and cost of compliance for
clinics across Asia Pacific. Medical facilities providing fertility services generally must be filed and registered with the relevant
supervision institutions and such filing and registration must be